ImunoTera
- Biotech or pharma, therapeutic R&D
ImunoTera has developed a platform of active immunotherapies that teach the immune system to recognize and eliminate cancer cells, generating a long-term memory capable of avoiding recurrences and metastases. The first product, called TERAH-7, is a therapeutic vaccine aimed at treating cancer caused by HPV, such as cervical cancer.



